|
|
Volumn 377, Issue 9760, 2011, Pages 121-122
|
|
Cabazitaxel for castration-resistant prostate cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CABAZITAXEL;
DOCETAXEL;
MITOXANTRONE;
PREDNISONE;
4 ACETOXY 13 ((3 ((TERT BUTOXYCARBONYL)AMINO) 2 HYDROXY 3 PHENYLPROPANOYL)OXY) 1 HYDROXY 7,10 DIMETHOXY 9 OXO 5,20 EPOXYTAX 11 EN 2 YL BENZOATE;
4-ACETOXY-13-((3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-3-PHENYLPROPANOYL)OXY)-1-HYDROXY-7,10-DIMETHOXY-9-OXO-5,20-EPOXYTAX-11-EN-2-YL BENZOATE;
ANTIANDROGEN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
TAXOID;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CASTRATION;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DIARRHEA;
DISEASE COURSE;
DRUG FATALITY;
FEMALE;
HEART DISEASE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
LETTER;
MALE;
MORTALITY;
NEUTROPENIA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
DRUG ADMINISTRATION;
DRUG EFFECT;
DRUG RESISTANCE;
HEART STROKE VOLUME;
IMMUNOLOGY;
NOTE;
PROSTATE TUMOR;
TREATMENT FAILURE;
TREATMENT OUTCOME;
SURVIVAL;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MALE;
MITOXANTRONE;
PREDNISONE;
PROSTATIC NEOPLASMS;
STROKE VOLUME;
TAXOIDS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
SURVIVAL ANALYSIS;
|
|
EID: 79251503603
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(11)60013-5 Document Type: Letter |
|
Times cited : (6)
|
|
References (2)
|
